A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder
- Cite this article as:
- Baker, D.G., Diamond, B.I., Gillette, G. et al. Psychopharmacology (1995) 122: 386. doi:10.1007/BF02246271
- 111 Views
A large multi-center, double-blind, parallel trial to assess the efficacy of brofaromine in the treatment of post traumatic stress disorder (PTSD) failed to show a significant difference between the brofaromine and placebo treatment groups. The placebo response rate in this study was higher than that in previously published double-blind, placebo-controlled studies of PTSD.